2022, assessed the risk of thromboembolic and thrombocytopenic events related to COVID-19 vaccines and found preliminary evidence of increased risk of both coronary disease and cardiovascular disease. 2022, found increased acute cardiac arrests and other acute cardiac events following mRNA COVID-19 vaccination.Īdditionally, Dag Berild J et al, JAMA Netw Open. This risk was 1 in 550 individuals, which is much higher than other vaccines.Ī second study, Sun CLF et al, Sci Rep. 2022, mRNA COVID-19 vaccines were associated with an excess risk of serious adverse events, including coagulation disorders, acute cardiac injuries, Bell’s palsy, and encephalitis. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) illustrating the risk factors associated with the mRNA COVID-19 vaccines and emphasizing the need for additional transparency.Īccording to a study, Fraiman J et al, Vaccine. To further evaluate this, the Surgeon General wrote a letter to the U.S. The findings in Florida are consistent with various studies that continue to uncover such risks. There is a need for additional unbiased research to better understand the COVID-19 vaccines' short- and long-term effects. This is a novel increase and was not seen during the 2009 H1N1 vaccination campaign. The reporting of life-threatening conditions increased over 4,400%. In Florida alone, there was a 1,700% increase in VAERS reports after the release of the COVID-19 vaccine, compared to an increase of 400% in overall vaccine administration for the same time period (Figure 1). Overall reports submitted to VAERS, Florida 2006–2022 The State Surgeon General is notifying the health care sector and public of a substantial increase in Vaccine Adverse Event Reporting System (VAERS) reports from Florida after the COVID-19 vaccine rollout. Although the initial response was led by a sense of urgency and crisis management, the State Surgeon General believes it is critical that as public health professionals, responses are adapted to the present to chart a future guided by data. “The implementation of those lessons is where we need to get to.The COVID-19 pandemic brought many challenges that the health and medical field have never encountered. “The lessons that need to be identified are not new ones,” says Michaud. Without big shifts in health policy infrastructure and messaging, we may be doomed to repeat the past. Millions of others who survive are suffering from long Covid, which produces a host of lingering symptoms like breathlessness and brain fog and remains frustratingly difficult to diagnose and treat. And it is still circulating. In April alone, the WHO reported, Covid-19 killed another 17,000. So far, the virus has killed nearly 7 million people worldwide (although that’s likely an undercount). Yet the end of the Covid emergency is far from a victory. It encourages countries to develop stronger data collection, use surveillance to identify variants, get high-risk groups vaccinated, and ensure that people who are diagnosed with Covid-19 have access to care. Last week, the organization released an updated plan for nations to cope with Covid-19. The WHO is hoping that some of these lessons will stick. At-home testing has always left gaps in national statistics and viral genetic sequencing efforts, says Peter Hotez, codirector of the Texas Children’s Hospital Center for Vaccine Development and dean of the National School of Tropical Medicine at Baylor College of Medicine. Should new variants begin circulating and bring Covid-19 roaring back in the fall, there will be less data available. The emergency declaration mandated that local data be provided, and that will now lapse.Īnd with less data, it will be harder to track new variants, which in turn will complicate the puzzle of updating vaccines to provide the most protection, although in some areas wastewater surveillance and genomic surveillance will continue. But when the US ends its emergency on May 11, the CDC will stop tracking community levels of transmission and instead will track overall hospitalization and death rates. That’s also true of cases and deaths in the EU. In the US, new cases, hospitalizations, and deaths are all trending downward, according to data from the US Centers for Disease Control and Prevention.
0 Comments
Leave a Reply. |